CYP19A1 and polycystic ovary syndrome: Likewise, a study conducted by Maliqueo et al. [111] reported reduced aromatase activity in placentae from patients diagnosed with polycystic ovarian syndrome (PCOS), when compared to controls, irrespective of sex.